Top Markets
#1 Orochi Network Orochi Network +71.79%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +24.63%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.75%
#7 Cheems Token Cheems Token +14.21%
#8 Taiko Taiko +13.85%
#9 Manadia Manadia +13.47%
#10 ROLL ROLL +13.27%
Coin of the day
Orochi Network Orochi Network
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rang in Aktien #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Aktienkurs
$50.95
Marktkapitalisierung
$226.41B
Veränderung (1 Tag)
2.58%
Veränderung (1 Jahr)
-26.16%
Land
DK
Handel Novo Nordisk A/S (NVO)

Kategorie

Healthcare
EPS für Novo Nordisk A/S (NVO)
EPS zum March 2026 TTM: $4.36
Laut den aktuellen Finanzberichten und dem Aktienkurs von Novo Nordisk A/S beträgt das aktuelle EPS des Unternehmens (TTM) $4.36. Am Ende des Jahres 2024 betrug das EPS $3.16 eine Steigerung gegenüber dem EPS von 2023, das $2.76 betrug.
EPS-Verlauf von Novo Nordisk A/S von 2000 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $4.36 20.40%
2025 $3.62 14.52%
2024 $3.16 14.42%
2023 $2.76 56.72%
2022 $1.76 10.96%
2021 $1.59 7.30%
2020 $1.48 20.24%
2019 $1.23 0.54%
2018 $1.23 -1.37%
2017 $1.24 16.81%
2016 $1.06 7.67%
2015 $0.99 20.28%
2014 $0.82 -5.24%
2013 $0.87 25.34%
2012 $0.69 31.26%
2011 $0.53 18.44%
2010 $0.44 28.33%
2009 $0.35 18.86%
2008 $0.29 9.87%
2007 $0.27 50.37%
2006 $0.18 25.27%
2005 $0.14 2.77%
2004 $0.14 13.97%
2003 $0.12 44.42%
2002 $0.08 24.70%
2001 $0.07 19.07%
2000 $0.06 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.01 290.29%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $42.53 875.84%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $9.62 120.75%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $23.88 447.92%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
 $4.36 0.04%
US